SOD1 and amyotrophic lateral sclerosis: These data align with previous data by our group demonstrating that mutant and wild-type SOD1 pathology in ALS patients likely forms from several convergent mechanisms [23]suggesting that coadministration of additional therapies targeting these as-of-yet unknown mechanisms may be required to completely ameliorate Parkinson-like wild-type disSOD1 pathology.